BN Business News
Añadir empresa →
Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.

Negocios · 6/2/20261 min de lectura

Matthew Teltser: Final Debarment Order

Traducción automática local · Idioma original de la fuente

Resumen

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) permanently debarring Matthew Teltser from providing services in any capacity to a person that has an approved or pending drug product application. FDA bases this order on a finding that Matthew Teltser was convicted of a felony under Federal law for conduct relating to the development or approval, including the process for development or approval, of any drug product. Dr. Teltser was given notice of the proposed permanent debarment and an opportunity to request a hearing to show why he should not be debarred within the timeframe prescribed by regulation. As of November 14, 2025 (more than 30 days after receipt of the notice), Dr. Teltser has not responded. Dr. Teltser's failure to respond and request a hearing constitutes a waiver of Dr. Teltser's right to a hearing concerning this matter.

Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →